T3 BioScience

David Yang, Board Director


Investor & Member of the Board of Directors since August 2017. David Yang holds a Bachelor Degree from the University of California, Irvine and is the Executive Director for 360T, the FX division of Deutsche Börse Group. Prior to Deutsche Börse, he was an executive sales manager for the New York Stock Exchange Group for Japan and Korea. David has 10 years experience as a sales executive responsible for Asian financial products on behalf of his companies. He will contribute to T3's sales strategy, its commercial business models and business development efforts.